{
    "nct_id": "NCT05223803",
    "official_title": "Phase 2 Randomized Total Eradication of Metastatic Lesions Following Definitive Radiation to the Prostate in De Novo OligometaStatic Prostate Cancer (TERPS) Trial",
    "inclusion_criteria": "1. Patient must have at least one and up to three asymptomatic metastatic tumor(s) of the bone or soft tissue (with at least one bone metastasis) develop within the past 6-months that are seen on imaging. Up to five lesions are allowed on advanced functional imaging such as fluciclovine (Axumin), choline or PSMA PET-CT scan.\n\n   1. CT or MRI scan within 6 months of enrollment\n   2. Bone scan within 6 months of enrollment\n   3. Fluciclovine (Axumin), choline, or PSMA PET-CT scan within 6 months of enrollment (PET-CT scan is reasonable for study entry imaging as an alternative to CT/MRI scan and bone scan)\n2. Histologic confirmation of malignancy (primary or metastatic tumor).\n3. Patient may have had prior systemic therapy and/or ADT associated with treatment within 9-months of enrollment.\n4. PSA > 0.5 but <100.\n5. Patient must be ≥ 18 years of age.\n6. Patient must have a life expectancy ≥ 12 months.\n7. Patient must have an ECOG performance status ≤ 2.\n8. Patient must have the ability to understand and the willingness to sign a written informed consent document\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Castration-resistant prostate cancer (CRPC).\n2. Prior radiation therapy to an overlapping site of a target lesion that would preclude further radiation therapy\n3. Spinal cord compression or impending spinal cord compression.\n4. Suspected pulmonary and/or liver metastases (greater >10 mm in largest axis).\n5. Patient receiving any other investigational agents.\n6. Inability to receive any form of systemic therapy in the opinion of a treating medical oncologist .\n7. Unable to lie flat during or tolerate PET/MRI, PET/CT or SABR.\n8. No radiographical evidence of cranial metastasis.\n9. Refusal to sign informed consent.",
    "miscellaneous_criteria": ""
}